Publications by authors named "Natale Schettini"

Article Synopsis
  • This study examines topical corticosteroid phobia (TCP) in women with vulvar lichen sclerosus (VLS) and how it affects their treatment adherence and outcomes.
  • The research involved 50 adult patients, who completed a questionnaire to assess their concerns about corticosteroid usage while undergoing a 12-week treatment, and most adhered well to the regimen.
  • Findings indicate that TCP levels were low among participants and did not negatively impact either their adherence to treatment or the effectiveness of the corticosteroid therapy.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigates whether the timing of dupilumab administration affects its effectiveness in treating patients with atopic dermatitis (AD), considering the body's natural biological rhythms.
  • The retrospective analysis involved 53 adult AD patients, comparing results based on whether they received dupilumab between midnight and noon or between noon and midnight over a 16-week period.
  • Findings indicate that while all patients showed clinical improvement, those who took dupilumab between midnight and noon experienced more significant enhancements, suggesting potential for optimizing treatment timing in future research.
View Article and Find Full Text PDF

Background And Objectives: We assessed the prevalence of oral lichen sclerosus in a cohort of women affected with vulvar lichen sclerosus (VLS).

Patients And Methods: This prospective, observational study included adult female patients with a histologically proven VLS who attended the Vulva Clinics of three Dermatology Units from January 2020 to July 2023. During this period, all VLS patients were asked to be examined in their oral cavities in order to detect any possible sign of oral diseases, which were then biopsied.

View Article and Find Full Text PDF
Article Synopsis
  • Dissecting cellulitis of the scalp (DCS) is a type of severe scalp condition characterized by pustules, nodules, and its association with other diseases like hidradenitis suppurativa (HS) and conglobate acne (CA).
  • In a case study, a patient with severe DCS, HS, and CA saw significant improvement after off-label treatment with secukinumab, unlike previous treatments which had little effect.
  • The management of DCS is difficult, often relying on retinoids, but recent literature suggests that biologic drugs like TNFα inhibitors can be effective, with few documented cases of treatment using IL-17 inhibitors like secukinumab for
View Article and Find Full Text PDF

OX40 is a co-stimulatory immune checkpoint molecule that promotes the activation and the effector function of T lymphocytes through interaction with its ligand (OX40L) on antigen-presenting cells. OX40-OX40L axis plays a crucial role in Th1 and Th2 cell expansion, particularly during the late phases or long-lasting response. Atopic dermatitis is characterized by an immune dysregulation of Th2 activity and by an overproduction of proinflammatory cytokines such as interleukin (IL)-4 and IL-13.

View Article and Find Full Text PDF

Atopic Dermatitis (AD) is the most prevalent inflammatory skin disorder resulting in an intense impact on patients quality of life. The aim of this study is to evaluate the clinical meaning of the DLQI scores documented between different phenotypes of AD patients under biologic therapy with Dupilumab. We conducted a retrospective analysis of 209 patients with AD treated with Dupilumab for 2 years.

View Article and Find Full Text PDF

Background: The pathophysiology of sensitive skin is largely unknown and no univocal data on the role of the epidermal barrier impairment have been identified. The aim of this study was to assess whether subjects with or without sensitive skin differ for some biophysical skin parameters, which reflect skin barrier integrity or skin hyperactivity.

Methods: This observational, cross-sectional study included adult volunteers not affected with chronic inflammatory skin diseases who attended the Unit of Dermatology and the Center of Cosmetology of the University of Ferrara, Ferrara, Italy, between March 2021 and November 2022.

View Article and Find Full Text PDF

Introduction: Vulvar lichen sclerosus (VLS) is characterized by progressive anatomical changes which become increasingly severe and irreversible. The objective of this study was to investigate if a "window of opportunity" exists in VLS, i.e.

View Article and Find Full Text PDF

Background And Objective: AtopyReg is a multicenter, prospective, observational, non-profit cohort study on moderate-to-severe atopic dermatitis in adults promoted in 2018 by the Italian Society of Dermatology and Venereology (SIDeMaST). We aimed to describe baseline demographics, disease characteristics, comorbidities, and therapeutic data of adult patients affected by moderate-to-severe atopic dermatitis.

Methods: Patients were selected based on the following inclusion criteria: age ≥ 18 years; Eczema Area and Severity Index score ≥ 16 or localization in visible or sensitive areas (face, neck, hands, or genitalia), or a Numeric Rating Scale itch score ≥ 7 or a Numeric Rating Scale sleep loss score ≥ 7, or a Dermatology Life Quality Index score ≥ 10.

View Article and Find Full Text PDF

Urticaria is an inflammatory skin disorder that may occur in isolation or associated with angioedema and/or anaphylaxis. Clinically, it is characterized by the presence of smooth, erythematous or blanching, itchy swelling, called wheals or hives, which greatly vary in size and shape and last less than 24 h before fading to leave normal skin. Urticaria is the consequence of mast-cell degranulation that can be caused by immunological or non-immunological mechanisms.

View Article and Find Full Text PDF
Article Synopsis
  • The systematic literature review aimed to analyze the effects of approved biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) on the synovial membrane in psoriatic arthritis (PsA) patients and explore potential biomarkers for treatment response.
  • A comprehensive search through various databases led to the inclusion of 22 studies, with the majority focusing on the effects of TNF inhibitors and using immunohistochemistry as the primary method for analysis.
  • The meta-analysis revealed a significant decrease in CD3+ lymphocytes and CD68+ macrophages in patients treated with bDMARDs, with the reduction in CD3+ cells correlating with clinical response, highlighting its potential as a reliable biomarker
View Article and Find Full Text PDF